Ownership Submission
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
Green Wyche T III
   2. Issuer Name and Ticker or Trading Symbol
GREENWAY MEDICAL TECHNOLOGIES INC [GWAY] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
President and CEO
(Last)
(First)
(Middle)
100 GREENWAY BOULEVARD		 3. Date of Earliest Transaction (Month/Day/Year)
11/04/2013
(Street)

CARROLLTON, GA 30117		 4. If Amendment, Date Original Filed(Month/Day/Year)
 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		 7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/30/2013   G V 5,000 D $ 0 57,236 D  
Common Stock 10/30/2013   G V 5,000 D $ 0 193,764 I By T&J Green Family Partnership LP
Common Stock 11/04/2013   D   57,236 D $ 20.35 0 D  
Common Stock 11/04/2013   D   193,764 D $ 20.35 0 I By T&J Green Family Partnership LP
Common Stock 11/04/2013   D   9,250 D $ 20.35 0 I By IRA
Common Stock 11/04/2013   D   9,600 D $ 20.35 0 I By Spouse

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)		 6. Date Exercisable and Expiration Date
(Month/Day/Year)		 7. Title and Amount of Underlying Securities
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)		 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)		 11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) $ 4.75 11/04/2013   D     20,000   (1) 02/16/2015 Common Stock 20,000 $ 15.6 0 D  
Stock Option (right to buy) $ 4.75 11/04/2013   D     54,700   (2) 08/18/2015 Common Stock 54,700 $ 15.6 0 D  
Stock Option (right to buy) $ 4.75 11/04/2013   D     75,701   (3) 10/18/2017 Common Stock 75,701 $ 15.6 0 D  
Stock Option (right to buy) $ 4.75 11/04/2013   D     4,184   (4) 09/18/2018 Common Stock 4,184 $ 15.6 0 D  
Stock Option (right to buy) $ 5.19 11/04/2013   D     500   (5) 09/15/2019 Common Stock 500 $ 15.16 0 D  
Stock Option (right to buy) $ 5.19 11/04/2013   D     30,000   (6) 11/04/2019 Common Stock 30,000 $ 15.16 0 D  
Stock Option (right to buy) $ 6.92 11/04/2013   D     15,000   (7) 10/18/2020 Common Stock 15,000 $ 13.43 0 D  
Stock Option (right to buy) $ 7.09 11/04/2013   D     125,000   (8) 02/01/2021 Common Stock 125,000 $ 13.26 0 D  
Stock Option (right to buy) $ 13.31 11/04/2013   D     15,000   (9) 07/14/2021 Common Stock 15,000 $ 7.04 0 D  
Stock Option (right to buy) $ 16.25 11/04/2013   D     107,500   (10) 05/30/2022 Common Stock 107,500 $ 4.1 0 D  
Stock Option (right to buy) $ 15.99 11/04/2013   D     106,000   (11) 09/24/2022 Common Stock 106,000 $ 4.36 0 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
Green Wyche T III
100 GREENWAY BOULEVARD
CARROLLTON, GA 30117		   X     President and CEO  

Signatures

 /s/ William G. Esslinger, Jr., as attorney-in-fact for Wyche T. Green, III   11/04/2013
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) This option, which is fully vested, was canceled in the merger in exchange for a cash payment of $312,000, representing the difference between the exercise price of the option and $20.35 per share of the underlying Greenway Medical Technologies, Inc. common stock.
(2) This option, which is fully vested, was canceled in the merger in exchange for a cash payment of $853,320, representing the difference between the exercise price of the option and $20.35 per share of the underlying Greenway Medical Technologies, Inc. common stock.
(3) This option, which is fully vested, was canceled in the merger in exchange for a cash payment of $1,180,935.60, representing the difference between the exercise price of the option and $20.35 per share of the underlying Greenway Medical Technologies, Inc. common stock.
(4) This option, which is fully vested, was canceled in the merger in exchange for a cash payment of $65,270.40, representing the difference between the exercise price of the option and $20.35 per share of the underlying Greenway Medical Technologies, Inc. common stock.
(5) This option, which is fully vested, was canceled in the merger in exchange for a cash payment of $7,580, representing the difference between the exercise price of the option and $20.35 per share of the underlying Greenway Medical Technologies, Inc. common stock.
(6) This option, which is fully vested, was canceled in the merger in exchange for a cash payment of $454,800, representing the difference between the exercise price of the option and $20.35 per share of the underlying Greenway Medical Technologies, Inc. common stock.
(7) This option, with 25% vesting on August 4, 2011 and the remainder vesting over three years thereafter in monthly installments, was canceled in the merger in exchange for a cash payment of $201,450, representing the difference between the exercise price of the option and $20.35 per share of the underlying Greenway Medical Technologies, Inc. common stock.
(8) This option, with 25% vesting on February 1, 2012 and the remainder vesting over three years thereafter in monthly installments, was canceled in the merger in exchange for a cash payment of $1,657,500, representing the difference between the exercise price of the option and $20.35 per share of the underlying Greenway Medical Technologies, Inc. common stock.
(9) This option, with 25% vesting on July 14, 2012 and the remainder vesting over three years thereafter in monthly installments, was canceled in the merger in exchange for a cash payment of $105,600, representing the difference between the exercise price of the option and $20.35 per share of the underlying Greenway Medical Technologies, Inc. common stock.
(10) This option, with 25% vesting on May 30, 2013 and the remainder vesting over three years thereafter in equal monthly installments, was canceled in the merger in exchange for a cash payment of $440,750, representing the difference between the exercise price of the option and $20.35 per share of the underlying Greenway Medical Technologies, Inc. common stock.
(11) This option, with 25% vesting on September 24, 2013 and the remainder vesting over three years thereafter in equal monthly installments, was canceled in the merger in exchange for a cash payment of $462,160, representing the difference between the exercise price of the option and $20.35 per share of the underlying Greenway Medical Technologies, Inc. common stock.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.